|

The SEQUENCE Trial

RECRUITINGN/ASponsored by Northwestern University
Actively Recruiting
PhaseN/A
SponsorNorthwestern University
Started2024-11-10
Est. completion2027-08
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations5 sites

Summary

This study will randomize participants undergoing a bronchoscopic biopsy of a peripheral pulmonary nodule for their standard of care to receive robotic-assisted bronchoscopy (RaB) and then staging linear endobronchial ultrasounnd (EBUS) OR staging linear EBUS first, followed by RaB. The goal of this study is to set the standard for optimizing the sequence of bronchoscopic procedures in patients at risk for early-stage malignancy.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Peripheral Pulmonary Nodule undergoing a robotic-assisted bronchoscopy

Exclusion Criteria:

* lymph nodes that are enlarged or PET avid on CT prior to procedure

Conditions3

CancerLung CancerPulmonary Nodules

Locations5 sites

California

1 site
University of California, Davis
Jeremy Kim

Illinois

1 site
Northwestern University
Chris Kapp, MD312-695-3800christopher.kapp@nm.org

Maryland

1 site
Johns Hopkins University
Jeffrey Thiboutotjthibou1@jhmi.edu

Michigan

1 site
University of Michigan
Ann Arbor, Michigan, 48109
Max Wayne

North Carolina

1 site
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, 27514
Jason Akulian

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.